Upregulation of P2RX7 in Cx3cr1-deficient mononuclear phagocytes leads to increased interleukin-1β secretion and photoreceptor neurodegeneration

SJ Hu, B Calippe, S Lavalette, C Roubeix… - Journal of …, 2015 - Soc Neuroscience
SJ Hu, B Calippe, S Lavalette, C Roubeix, F Montassar, M Housset, O Levy, C Delarasse
Journal of Neuroscience, 2015Soc Neuroscience
Photoreceptor degeneration in age-related macular degeneration (AMD) is associated with
an infiltration and chronic accumulation of mononuclear phagocytes (MPs). We have
previously shown that Cx3cr1-deficient mice develop age-and stress-related subretinal
accumulation of MPs, which is associated with photoreceptor degeneration. Cx3cr1-deficient
MPs have been shown to increase neuronal apoptosis through IL-1β in neuroinflammation
of the brain. The reason for increased IL-1β secretion from Cx3cr1-deficient MPs, and …
Photoreceptor degeneration in age-related macular degeneration (AMD) is associated with an infiltration and chronic accumulation of mononuclear phagocytes (MPs). We have previously shown that Cx3cr1-deficient mice develop age- and stress- related subretinal accumulation of MPs, which is associated with photoreceptor degeneration. Cx3cr1-deficient MPs have been shown to increase neuronal apoptosis through IL-1β in neuroinflammation of the brain. The reason for increased IL-1β secretion from Cx3cr1-deficient MPs, and whether IL-1β is responsible for increased photoreceptor apoptosis in Cx3cr1-deficient mice, has not been elucidated. Here we show that Cx3cr1-deficient MPs express increased surface P2X7 receptor (P2RX7), which stimulates IL-1β maturation and secretion. P2RX7 and IL-1β inhibition efficiently blunted Cx3cr1-MP-dependent photoreceptor apoptosis in a monocyte/retina coculture system and in light-induced subretinal inflammation of Cx3cr1-deficient mice in vivo. Our results provide an explanation for increased CX3CR1-dependent IL-1β secretion and suggest that IL-1β or P2RX7 inhibition can help inhibit the inflammation-associated photoreceptor cell loss in late AMD, including geographic atrophy, for which no efficient treatment currently exists.
Soc Neuroscience